|
"lu s n"的相關文件
顯示項目 121-130 / 140 (共14頁)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2020 |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
|
Douillard J.-Y.; Yoshino T.; CHIH-HUNG HSU; Yen Y.; Tabernero J.; Shen Y.-C.; Hsu C.; Ren Z.; Malhotra H.; Ueno M.; Ryoo B.-Y.; Kiang T.C.; Tai D.; Vogel A.; Cervantes A.; Lu S.-N.; Yen C.-J.; Huang Y.-H.; Chen S.-C.; Cheng A.-L.; Martinelli E.; Chen L.-T.; Chen L.-T.;Martinelli E.;Cheng A.-L.;Pentheroudakis G.;Qin S.;Bhattacharyya G.S.;Ikeda M.;Lim H.-Y.;Ho G.F.;Choo S.P.;Ren Z.;Malhotra H.;Ueno M.;Ryoo B.-Y.;Kiang T.C.;Tai D.;Vogel A.;Cervantes A.;Lu S.-N.;Yen C.-J.;Huang Y.-H.;Chen S.-C.;Hsu C.;Shen Y.-C.;Tabernero J.;Yen Y.;Chih-Hung Hsu;Yoshino T.;Douillard J.-Y.; Choo S.P.; Ho G.F.; Lim H.-Y.; Ikeda M.; Bhattacharyya G.S.; Qin S.; Pentheroudakis G. |
| 國立成功大學 |
2020 |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
|
Chen, L.-T.;Martinelli, E.;Cheng, A.-L.;Pentheroudakis, G.;Qin, S.;Bhattacharyya, G.S.;Ikeda, M.;Lim, H.-Y.;Ho, G.F.;Choo, S.P.;Ren, Z.;Malhotra, H.;Ueno, M.;Ryoo, B.-Y.;Kiang, T.C.;Tai, D.;Vogel, A.;Cervantes, A.;Lu, S.-N.;Yen, C.-J.;Huang, Y.-H.;Chen, S.-C.;Hsu, C.;Shen, Y.-C.;Tabernero, J.;Yen, Yen Y.;Hsu, C.-H.;Yoshino, T.;Douillard, J.-Y. |
| 臺大學術典藏 |
2018-09-10T18:06:03Z |
Hepatitis C viral load, genotype, and increased risk of developing end-stage renal disease: REVEAL-HCV study
|
Lai, T.-S. ; Lee, M.-H. ; Yang, H.-I. ; You, S.-L. ; Lu, S.-N. ; Wang, L.-Y. ; Yuan, Y. ; L'Italien, G. ; Chien, K.-L. ; Chen, C.-J.; TAI-SHUAN LAI; KUO-LIONG CHIEN |
| 臺大學術典藏 |
2018-09-10T18:06:03Z |
High hepatitis C viral load and genotype 2 are strong predictors of chronic kidney disease
|
Lai, T.-S. ; Lee, M.-H. ; Yang, H.-I. ; You, S.-L. ; Lu, S.-N. ; Wang, L.-Y. ; Yuan, Y. ; L'Italien, G. ; Chien, K.-L. ; Chen, C.-J.; TAI-SHUAN LAI; KUO-LIONG CHIEN |
| 臺大學術典藏 |
2018-09-10T18:02:16Z |
Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients
|
Lee, M.-H.;Huang, C.-F.;Lai, H.-C.;Lin, C.-Y.;Dai, C.-Y.;Liu, C.-J.;Wang, J.-H.;Huang, J.-F.;Su, W.-P.;Yang, H.-C.;Kee, K.-M.;Yeh, M.-L.;Chuang, P.-H.;Hsu, S.-J.;Huang, C.-I.;Kao, J.-T.;Chen, C.-C.;Chen, S.-H.;Jeng, W.-J.;Yang, H.-I.;Yuan, Y.;Lu, S.-N.;Sheen, I.-S.;Liu, C.-H.;Peng, C.-Y.;Kao, J.-H.;Yu, M.-L.;Chuang, W.-L.;Chen, C.-J.; HUNG-CHIH YANG; CHUN-JEN LIU; CHEN-HUA LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T15:17:28Z |
A polymorphism in interferon L3 Is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis c virus infection
|
Chang, K.-C. ; Tseng, P.-L. ; Wu, Y.-Y. ; Hung, H.-C. ; Huang, C.-M. ; Lu, S.-N. ; Wang, J.-H. ; Lee, C.-M. ; Chen, C.-H. ; Tsai, M.-C. ; Yen, Y.-H. ; Lin, M.-T. ; Wu, C.-K. ; Huang, C.-C. ; Chen, H.-H. ; Hu, T.-H.; HSIU-HSI CHEN |
| 臺大學術典藏 |
2018-09-10T14:59:09Z |
Distinct seromarkers predict different milestones of chronic hepatitis B progression
|
Liu, J. ; Yang, H.-I. ; Lee, M.-H. ; Batrla-Utermann, R. ; Jen, C.-L. ; Lu, S.-N. ; Wang, L.-Y. ; You, S.-L. ; Hsiao, C.K. ; Chen, C.-J.; CHUHSING KATE HSIAO |
| 臺大學術典藏 |
2018-09-10T09:41:04Z |
Clinical-guide risk prediction of hepatocellular carcinoma development in chronic hepatitis C patients after interferon-based therapy
|
Chang, K-C;Wu, Y-Y;Hung, C-H;Lu, S-N;Lee, C-M;Chiu, K-W;Tsai, M-C;Tseng, P-L;Huang, C-M;Cho, C-L;Chen, H-H;Hu, T-H; HSIU-HSI CHEN; Chang, K-C; Wu, Y-Y; Hung, C-H; Lu, S-N; Lee, C-M; Chiu, K-W; Tsai, M-C; Tseng, P-L; Huang, C-M; Cho, C-L; Chen, H-H; Hu, T-H |
| 臺大學術典藏 |
2018-09-10T08:44:32Z |
Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses
|
Yeh, M.-L.; Hung, C.-H.; Huang, J.-F.; Liu, C.-J.; Lee, C.-M.; Dai, C.-Y.; Wang, J.-H.; Lin, Z.-Y.; Lu, S.-N.; Hu, T.-H.; Yu, M.-L.; Kao, J.-H.; Chuang, W.-L.; Chen, P.-J.; Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T04:06:00Z |
Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan
|
Chen, T.H.-H.;Chen, C.-J.;Yen, M.-F.;Lu, S.-N.;Sun, C.-A.;Huang, G.-T.;Yang, P.-M.;Lee, H.-S.;Duffy, S.W.; Chen, T.H.-H.; Chen, C.-J.; Yen, M.-F.; Lu, S.-N.; Sun, C.-A.; Huang, G.-T.; Yang, P.-M.; Lee, H.-S.; Duffy, S.W.; HSUAN-SHU LEE; HSIU-HSI CHEN; GUAN-TARN HUANG; PEI-MING YANG |
顯示項目 121-130 / 140 (共14頁)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
每頁顯示[10|25|50]項目
|
